TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors
- PMID: 20821041
- PMCID: PMC3064903
- DOI: 10.1007/s10875-010-9456-8
TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors
Erratum in
- J Clin Immunol. 2011 Feb;31(1):136
Abstract
Recently, it has been reported that using multiple signals, murine and human B cells secrete several cytokines with pro-inflammatory and immunoregulatory properties. We present the first comprehensive analysis of 24 cytokines, chemokines, and hematopoietic growth factors production by purified human peripheral blood B cells (CD19+), and naive (CD19+CD27-) and memory (CD19+CD27+) B cells in response to direct and exclusive signaling provided by toll-like receptor (TLR) ligands Pam3CSK (TLR1/TLR2), Imiquimod (TLR7), and GpG-ODN2006 (TLR9). All three TLR ligands stimulated B cells (CD19+) to produce cytokines IL-1α, IL-1β, IL-6, TNF-α, IL-13, and IL-10, and chemokines MIP-1α, MIP-1β, MCP-1, IP-10, and IL-8. However, GM-CSF and G-CSF production was predominantly induced by TLR2 agonist. Most cytokines/chemokines/hematopoietic growth factors were predominantly or exclusively produced by memory B cells, and in general, TLR2 signal was more powerful than signal provided viaTLR7 and TLR9. No significant secretion of eotaxin, IFN-α, IFN-γ, IL-2, IL-3, IL-4, IL-5, IL-7, IL-15, IL-17, IL-12p40, IL-12p70, and TNF-β (lymphotoxin) was observed. These data demonstrate that human B cells can be directly activated viaTLR1/TLR2, TLR7, and TLR9 to induce secretion of cytokines, chemokines, and hematopoietic growth factors and suggest a role of B cells in immune response against microbial pathogenesis and immune homeostasis.
Figures







Similar articles
-
Toll-like receptor 7 and 9 defects in common variable immunodeficiency.J Allergy Clin Immunol. 2009 Aug;124(2):349-56, 356.e1-3. doi: 10.1016/j.jaci.2009.05.019. Epub 2009 Jul 9. J Allergy Clin Immunol. 2009. PMID: 19592080 Free PMC article.
-
Comparison of human B cell activation by TLR7 and TLR9 agonists.BMC Immunol. 2008 Jul 24;9:39. doi: 10.1186/1471-2172-9-39. BMC Immunol. 2008. PMID: 18652679 Free PMC article.
-
The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.Br J Dermatol. 2015 Jan;172(1):48-55. doi: 10.1111/bjd.13214. Epub 2014 Nov 20. Br J Dermatol. 2015. PMID: 24976336
-
[Toll-like receptors recognizing ligands of herpesvirus].Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr;(2):108-11. Zh Mikrobiol Epidemiol Immunobiol. 2009. PMID: 19459489 Review. Russian.
-
Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8+ T cell cytokine production.Scand J Immunol. 2021 May;93(5):e13019. doi: 10.1111/sji.13019. Epub 2021 Jan 19. Scand J Immunol. 2021. PMID: 33377182 Review.
Cited by
-
(R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism.Cells. 2020 Feb 24;9(2):511. doi: 10.3390/cells9020511. Cells. 2020. PMID: 32102363 Free PMC article.
-
Why Should We Consider Potential Roles of Oral Bacteria in the Pathogenesis of Sjögren Syndrome?Immune Netw. 2022 Aug 3;22(4):e32. doi: 10.4110/in.2022.22.e32. eCollection 2022 Aug. Immune Netw. 2022. PMID: 36081525 Free PMC article. Review.
-
Therapeutic applications of toll-like receptors (TLRs) agonists in AML.Clin Transl Oncol. 2022 Dec;24(12):2319-2329. doi: 10.1007/s12094-022-02917-5. Epub 2022 Aug 13. Clin Transl Oncol. 2022. PMID: 35962918 Review.
-
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy.Front Immunol. 2023 Oct 23;14:1227833. doi: 10.3389/fimmu.2023.1227833. eCollection 2023. Front Immunol. 2023. PMID: 37936697 Free PMC article. Review.
-
IL-10: A Multifunctional Cytokine in Viral Infections.J Immunol Res. 2017;2017:6104054. doi: 10.1155/2017/6104054. Epub 2017 Feb 20. J Immunol Res. 2017. PMID: 28316998 Free PMC article. Review.
References
-
- Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705–710. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous